The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe

被引:2
作者
Smit, Mikaela [1 ]
Olney, Jack [1 ]
Ford, Nathan P. [2 ]
Vitoria, Marco [2 ]
Gregson, Simon [1 ,3 ]
Vassall, Anna [4 ]
Hallett, Timothy B. [1 ]
机构
[1] Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus, London W2 1PG, England
[2] WHO, Dept HIV AIDS & Global Hepatitis Programme, Geneva, Switzerland
[3] Biomed Res & Training Inst, Harare, Zimbabwe
[4] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England
关键词
ageing; HIV; model; noncommunicable diseases; Zimbabwe; INDIVIDUALS; INFECTION; PROGRESSION; CHALLENGES; PREVALENCE;
D O I
10.1097/QAD.0000000000001754
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: We aim to characterize the future noncommunicable disease (NCD) burden in Zimbabwe to identify future health system priorities. Methods: We developed an individual-based multidisease model for Zimbabwe, simulating births, deaths, infection with HIV and progression and key NCD [asthma, chronic kidney disease (CKD), depression, diabetes, hypertension, stroke, breast, cervical, colorectal, liver, oesophageal, prostate and all other cancers]. The model was parameterized using national and regional surveillance and epidemiological data. Demographic and NCD burden projections were generated for 2015 to 2035. Results: The model predicts that mean age of PLHIV will increase from 31 to 45 years between 2015 and 2035 (compared with 20-26 in uninfected individuals). Consequently, the proportion suffering from at least one key NCD in 2035 will increase by 26% in PLHIV and 6% in uninfected. Adult PLHIV will be twice as likely to suffer from at least one key NCD in 2035 compared with uninfected adults; with 15.2% of all key NCDs diagnosed in adult PLHIV, whereas contributing only 5% of the Zimbabwean population. The most prevalent NCDs will be hypertension, CKD, depression and cancers. This demographic and disease shift in PLHIV is mainly because of reductions in incidence and the success of ART scale-up leading to longer life expectancy, and to a lesser extent, the cumulative exposure to HIV and ART. Conclusion: NCD services will need to be expanded in Zimbabwe. They will need to be integrated into HIV care programmes, although the growing NCD burden amongst uninfected individuals presenting opportunities for additional services developed within HIV care to benefit HIV-negative persons. Copyright (C) 2018 The Author(s). Published by Wolters Kluwer Health, Inc.
引用
收藏
页码:773 / 782
页数:10
相关论文
共 30 条
[1]  
Abu-Raddad LJ, DUAL INFECT HIV MALA
[2]  
African Health Observatory World Health Organisation, COMPR AN PROF ZIMB
[3]   Tackling Africa's chronic disease burden: from the local to the global [J].
Aikins, Ama de-Graft ;
Unwin, Nigel ;
Agyemang, Charles ;
Allotey, Pascale ;
Campbell, Catherine ;
Arhinful, Daniel .
GLOBALIZATION AND HEALTH, 2010, 6
[4]   HIV and ageing: improving quantity and quality of life [J].
Althoff, Keri N. ;
Smit, Mikaela ;
Reiss, Peter ;
Justice, Amy C. .
CURRENT OPINION IN HIV AND AIDS, 2016, 11 (05) :527-536
[5]  
[Anonymous], THE GAP REP 2014
[6]  
Badri M, 2001, INT J TUBERC LUNG D, V5, P225
[7]   Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study [J].
Cornell, Morna ;
Johnson, Leigh F. ;
Schomaker, Michael ;
Tanser, Frank ;
Maskew, Mhairi ;
Wood, Robin ;
Prozesky, Hans ;
Giddy, Janet ;
Stinson, Kathryn ;
Egger, Matthias ;
Boulle, Andrew ;
Myer, Landon .
LANCET HIV, 2015, 2 (09) :E368-E375
[8]   HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review [J].
Gregson, Simon ;
Gonese, Elizabeth ;
Hallett, Timothy B. ;
Taruberekera, Noah ;
Hargrove, John W. ;
Lopman, Ben ;
Corbett, Elizabeth L. ;
Dorrington, Rob ;
Dube, Sabada ;
Dehne, Karl ;
Mugurungi, Owen .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2010, 39 (05) :1311-1323
[9]  
IHME, I HLTHMETR EV MDG VI
[10]   Schistosomiasis and HIV-1 infection in rural Zimbabwe: Effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load [J].
Kallestrup, P ;
Zinyama, R ;
Gomo, E ;
Butterworth, AE ;
Mudenge, B ;
van Dam, GJ ;
Gerstoft, J ;
Erikstrup, C ;
Ullum, H .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (11) :1956-1961